packageDermatanSulfate

dermatan sulfate

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Dermatan sulfate, a glycosaminoglycan also known as chondroitin sulfate B, has been investigated as an antithrombotic agent for preventing blood clots. It remains an investigational compound and is not an approved medicine in the European Union.

Summary written by glm-5.3-flash from Wikidata Q2335618 and the WHO ATC classification; not checked by a person.

name:dermatan sulfate
ATC codes:B01AX04
DrugBank:DB15880
Wikidata:Q2335618
formula:C14H21NO15S
molar mass:475.38 g/mol (knowledgebase (DrugBank calculated))
logP:-4.3 (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown